News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
857,487 Results
Type
Article (78239)
Company Profile (719)
Press Release (778507)
Multimedia
Podcasts (230)
Webinars (35)
Section
Business (229006)
Career Advice (3812)
Deals (39478)
Drug Delivery (177)
Drug Development (90064)
Employer Resources (207)
FDA (18313)
Job Trends (17273)
News (390640)
Policy (39104)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3052)
Academic (2)
Accelerated approval (56)
ADA (49)
Adcomms (40)
Allergies (199)
Alliances (56316)
ALS (235)
Alzheimer's disease (1967)
Antibody-drug conjugate (ADC) (552)
Approvals (18655)
Artificial intelligence (829)
ASCO (344)
Autoimmune disease (361)
Automation (63)
Bankruptcy (404)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (248)
Biotechnology (441)
Bladder cancer (209)
Brain cancer (85)
Breast cancer (835)
Cancer (6551)
Cardiovascular disease (552)
Career advice (3281)
Career pathing (52)
CAR-T (385)
CDC (76)
Celiac Disease (3)
Cell therapy (1056)
Cervical cancer (54)
Clinical research (77744)
Collaboration (2371)
Company closure (8)
Compensation (1512)
Complete response letters (106)
COVID-19 (3040)
CRISPR (124)
C-suite (1285)
Cystic fibrosis (167)
Data (8691)
Decentralized trials (3)
Denatured (88)
Depression (192)
Dermatology (97)
Diabetes (698)
Diagnostics (7591)
Digital health (68)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (402)
Drug pricing (244)
Drug shortages (39)
Duchenne muscular dystrophy (318)
Earnings (99969)
Editorial (78)
Employer branding (25)
Employer resources (174)
Events (137747)
Executive appointments (1193)
FDA (22370)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (19)
Frontotemporal dementia (36)
Funding (1934)
Gene editing (271)
Generative AI (82)
Gene therapy (842)
GLP-1 (1283)
Government (5549)
Grass and pollen (8)
Guidances (420)
Healthcare (21251)
Hematology (197)
HIV (94)
Huntington's disease (64)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (115)
Immunology and inflammation (352)
Immuno-oncology (116)
Indications (206)
Infectious disease (3436)
Inflammatory bowel disease (242)
Inflation Reduction Act (17)
Influenza (147)
Intellectual property (321)
Interviews (750)
IPO (17895)
IRA (61)
Job creations (4996)
Job search strategy (2638)
JPM (73)
Kidney cancer (22)
Labor market (122)
Layoffs (682)
Leadership (53)
Legal (9984)
Liver cancer (111)
Longevity (36)
Lung cancer (871)
Lymphoma (470)
Machine learning (65)
Management (66)
Manufacturing (1210)
MASH (226)
Medical device (15254)
Medtech (15414)
Mergers & acquisitions (22884)
Metabolic disorders (1815)
mRNA (266)
Multiple sclerosis (204)
NASH (24)
Neurodegenerative disease (507)
Neuropsychiatric disorders (126)
Neuroscience (3707)
Neurotech (1)
NextGen: Class of 2026 (7666)
Non-profit (5146)
Now hiring (80)
Obesity (870)
Opinion (374)
Ovarian cancer (243)
Pain (284)
Pancreatic cancer (352)
Parkinson's disease (415)
Partnered (37)
Patents (650)
Patient recruitment (763)
Peanut (70)
People (66925)
Pharmaceutical (125)
Pharmacy benefit managers (37)
Phase 1 (24052)
Phase 2 (33895)
Phase 3 (25521)
Pipeline (9755)
Policy (397)
Postmarket research (3295)
Preclinical (10649)
Press Release (72)
Prostate cancer (345)
Psychedelics (68)
Radiopharmaceuticals (372)
Rare diseases (1263)
Real estate (7233)
Recruiting (81)
Regulatory (29672)
Reports (77)
Research institute (2766)
Resumes & cover letters (594)
Rett syndrome (43)
RNA editing (29)
RSV (98)
Schizophrenia (196)
Series A (327)
Series B (237)
Service/supplier (26)
Sickle cell disease (127)
Special edition (32)
Spinal muscular atrophy (189)
Sponsored (55)
Startups (4275)
State (2)
Stomach cancer (21)
Supply chain (146)
Tariffs (104)
The Weekly (139)
Vaccines (1303)
Venture capital (134)
Weight loss (597)
Women's health (139)
Worklife (24)
Date
Last 7 days (644)
Last 30 days (2788)
Last 365 days (32759)
2026 (16127)
2025 (32655)
2024 (37903)
2023 (42563)
2022 (53927)
2021 (58718)
2020 (57663)
2019 (51324)
2018 (39102)
2017 (36867)
2016 (37812)
2015 (43845)
2014 (38591)
2013 (34729)
2012 (36592)
2011 (36641)
2010 (36198)
Location
Africa (1226)
Alabama (102)
Alaska (7)
Arizona (384)
Arkansas (16)
Asia (50707)
Australia (8711)
California (14362)
Canada (3994)
China (1573)
Colorado (620)
Connecticut (638)
Delaware (441)
Europe (116134)
Florida (2132)
Georgia (467)
Hawaii (4)
Idaho (69)
Illinois (1235)
India (101)
Indiana (663)
Iowa (25)
Japan (594)
Kansas (142)
Kentucky (57)
Louisiana (64)
Maine (89)
Maryland (1739)
Massachusetts (10509)
Michigan (415)
Minnesota (799)
Mississippi (7)
Missouri (164)
Montana (37)
Nebraska (30)
Nevada (153)
New Hampshire (92)
New Jersey (3811)
New Mexico (35)
New York (3776)
North Carolina (1928)
North Dakota (11)
Northern California (7152)
Ohio (446)
Oklahoma (27)
Oregon (53)
Pennsylvania (2825)
Puerto Rico (30)
Rhode Island (54)
South America (1588)
South Carolina (88)
South Dakota (2)
Southern California (5639)
Tennessee (227)
Texas (2328)
United States (51316)
Utah (427)
Vermont (1)
Virginia (365)
Washington D.C. (89)
Washington State (1177)
West Virginia (4)
Wisconsin (158)
Wyoming (2)
857,487 Results for "kohlberg kravis roberts and co l p".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GCAR and Purdue Pharma L.P. Announce Initiation of Tinostamustine in GBM AGILE Trial
April 8, 2026
·
6 min read
Press Releases
OS Therapies Appoints Biotech Industry Luminary Robert “Bob” S. Langer, PhD as Strategic Advisor
• Co-founder of more than 40 biotechnology companies, including 16 IPOs and 19 successful acquisitions • Scientific and medical titan focused on driving innovation for human health • Will assist with listeria oncology pipeline prioritization, combinations with other oncology-focused biotechnologies and tADC candidate selection for further development
April 13, 2026
·
8 min read
Press Releases
Insulet Announces Appointment of Robert L. Huffines to its Board of Directors
October 23, 2025
·
3 min read
Press Releases
Inside the 98 Percent: L7 Informatics on the Operational Harness That Determines Pharma’s Agentic AI Outcomes
L7 Informatics CEO, Vasu Rangadass, Ph.D., examines the architectural principle separating pharmaceutical AI experimentation from enterprise-scale deployment.
June 12, 2026
·
1 min read
Press Releases
Digital Disruption in Life Sciences: L7 Informatics Says Competitive Advantage Will Come From Governed Execution
L7 Informatics CEO explains why the next wave of life sciences innovation depends on digital unified platforms that orchestrate workflows, contextualize data, and enable AI-actionable operations.
February 12, 2026
·
1 min read
Press Releases
Co-Diagnostics Advances Latin American Commercialization Strategy for Co-Dx™ PCR Pro® with Mexico Distributor Agreement
June 11, 2026
·
5 min read
Opinion
The real potential of PD-(L)1×VEGF bispecifics may be outside lung cancer
PD-(L)1×VEGF bispecifics have emerged as a closely watched new class in immuno-oncology, with multiple candidates advancing through trials in lung cancer. But the potential of these drugs may be highest in cancers where angiogenesis and immune escape are tightly intertwined.
May 28, 2026
·
6 min read
·
Souro Chowdhury
Press Releases
CollectiveMinds LLC Places Robert Hollingsworth, PhD as Chief Scientific Officer of Protillion Biosciences
April 1, 2026
·
4 min read
Press Releases
Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities
June 3, 2026
·
5 min read
Press Releases
Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC Published in The Lancet
June 1, 2026
·
7 min read
1 of 85,749
Next
